ACTION study: efficacy of nifedipine in preventing cardiovascular disease in patients with coronary artery disease

Hiroaki Shimokawa

研究成果: Review article

1 引用 (Scopus)

抜粋

Recent reports show that nifedipine not only causes vasodilation but also exerts beneficial effects on the endothelium of blood vessels. Some clinical trials evaluated nifedipine GITS (gastrointestinal therapeutic system) in patients with coronary artery disease. The investigators found that the treatment with nifedipine improved acetylcholine reactivity in coronary arteries and inhibited increases in coronary plaque volume. Furthermore, the large randomised, double-blind, placebo-controlled ACTION (A Coronary Disease Trial Investigating Outcome with Nifedipine GITS) study in patients with stable angina pectoris revealed that the treatment with nifedipine GITS led to significant reductions in the onset of overt heart failure and in the need for coronary angiography or coronary artery bypass graft surgery. These data indicate that a direct action on blood vessels, rather than coronary vasodilating or antihypertensive effects, might be responsible for improved prognosis with nifedipine.

元の言語English
ページ(範囲)10-12
ページ数3
ジャーナルDrugs
66 Spec No 1
DOI
出版物ステータスPublished - 2006

ASJC Scopus subject areas

  • Pharmacology (medical)

フィンガープリント ACTION study: efficacy of nifedipine in preventing cardiovascular disease in patients with coronary artery disease' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用